These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26883593)

  • 1. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.
    Wong Fok Lung T; Giogha C; Creuzburg K; Ong SY; Pollock GL; Zhang Y; Fung KY; Pearson JS; Hartland EL
    Infect Immun; 2016 May; 84(5):1346-1360. PubMed ID: 26883593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).
    Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL
    J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NleB/SseK effectors from
    El Qaidi S; Chen K; Halim A; Siukstaite L; Rueter C; Hurtado-Guerrero R; Clausen H; Hardwidge PR
    J Biol Chem; 2017 Jul; 292(27):11423-11430. PubMed ID: 28522607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli.
    Pollock GL; Oates CVL; Giogha C; Wong Fok Lung T; Ong SY; Pearson JS; Hartland EL
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A type III effector antagonizes death receptor signalling during bacterial gut infection.
    Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL
    Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector.
    Giogha C; Scott NE; Wong Fok Lung T; Pollock GL; Harper M; Goddard-Borger ED; Pearson JS; Hartland EL
    PLoS Pathog; 2021 Jun; 17(6):e1009658. PubMed ID: 34133469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the pst-phoU operon to cell adherence by atypical enteropathogenic Escherichia coli and virulence of Citrobacter rodentium.
    Cheng C; Tennant SM; Azzopardi KI; Bennett-Wood V; Hartland EL; Robins-Browne RM; Tauschek M
    Infect Immun; 2009 May; 77(5):1936-44. PubMed ID: 19255191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains.
    Li S; Zhang L; Yao Q; Li L; Dong N; Rong J; Gao W; Ding X; Sun L; Chen X; Chen S; Shao F
    Nature; 2013 Sep; 501(7466):242-6. PubMed ID: 23955153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.
    Girard F; Crepin VF; Frankel G
    Infect Immun; 2009 Apr; 77(4):1304-14. PubMed ID: 19188355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK.
    Creuzburg K; Giogha C; Wong Fok Lung T; Scott NE; Mühlen S; Hartland EL; Pearson JS
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27872241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A surprising sweetener from enteropathogenic Escherichia coli.
    Pearson JS; Hartland EL
    Gut Microbes; 2014; 5(6):766-9. PubMed ID: 25536377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells.
    Pallett MA; Crepin VF; Serafini N; Habibzay M; Kotik O; Sanchez-Garrido J; Di Santo JP; Shenoy AR; Berger CN; Frankel G
    Mucosal Immunol; 2017 May; 10(3):602-612. PubMed ID: 27624779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
    Thanabalasuriar A; Kim J; Gruenheid S
    Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium.
    Lee SF; Kelly M; McAlister A; Luck SN; Garcia EL; Hall RA; Robins-Browne RM; Frankel G; Hartland EL
    Cell Microbiol; 2008 Feb; 10(2):499-513. PubMed ID: 17979986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence.
    Runte CS; Jain U; Getz LJ; Secord S; Kuwae A; Abe A; LeBlanc JJ; Stadnyk AW; Kaper JB; Hansen AM; Thomas NA
    Mol Microbiol; 2018 Jun; 108(5):536-550. PubMed ID: 29509331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic DxD motif caged in Asx-turn and Met-aromatic interaction attenuates the pathogenic glycosylation of SseK2/NleB2 effectors.
    Koh E; Kim U; Cho HS
    Sci Rep; 2022 Nov; 12(1):19288. PubMed ID: 36369343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
    Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
    Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium.
    Kelly M; Hart E; Mundy R; Marchès O; Wiles S; Badea L; Luck S; Tauschek M; Frankel G; Robins-Browne RM; Hartland EL
    Infect Immun; 2006 Apr; 74(4):2328-37. PubMed ID: 16552063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and Functional Insights into Host Death Domains Inactivation by the Bacterial Arginine GlcNAcyltransferase Effector.
    Ding J; Pan X; Du L; Yao Q; Xue J; Yao H; Wang DC; Li S; Shao F
    Mol Cell; 2019 Jun; 74(5):922-935.e6. PubMed ID: 30979585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citrobacter rodentium virulence in mice associates with bacterial load and the type III effector NleE.
    Wickham ME; Lupp C; Vázquez A; Mascarenhas M; Coburn B; Coombes BK; Karmali MA; Puente JL; Deng W; Finlay BB
    Microbes Infect; 2007 Mar; 9(3):400-7. PubMed ID: 17317262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.